A synthetic biphasic calcium phosphate material proved as reliable after a year as deproteinized cow bone for sinus augmentation in a clinical implant trial reported online May 11 in Clinical Implant ...
Maxillary sinus augmentation remains a cornerstone intervention for addressing insufficient bone height in the posterior maxilla prior to dental implant placement. Techniques such as the lateral ...
With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global Sinus Implants Market as well as the factors responsible for ...
Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following ...
Intersect ENT received CMS approval of a revised coding application for its Propel sinus implant, according to a Jan. 19 news release. Propel previously shared a billing code with Intersect ENT’s ...
Recent med tech IPO candidate Intersect ENT ($XENT) has reported the results of three studies for its chronic sinusitis implants at the American Rhinologic Society ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Sinus Implants Market research Report is an inestimable supply of insightful data for business strategists. This Sinus Implants Market study provides extensive data which enlarge the understanding, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback